Screener
AnaptysBio, Inc. ANAB Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash provided by investing activities | 34,983 | 14,847 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from issuance of common stock | 14,021 | 290 |
| Repurchase and retirements of common stock | — | (4,424) |
| Payment for net share settlement of equity awards | — | (1,451) |
| Principal repayment of liability for sale of future royalties | (12,812) | (23,005) |
| Net cash provided by (used in) financing activities | 1,209 | (28,590) |
| Net increase (decrease) in cash and cash equivalents | 10,273 | (24,443) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s share buybacks?
- AnaptysBio, Inc. (ANAB) reported share buybacks of $0 in Q1 2026.
- How has AnaptysBio, Inc.'s share buybacks changed year-over-year?
- AnaptysBio, Inc.'s share buybacks decreased by 100.0% year-over-year, from $4.42M to $0.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about AnaptysBio, Inc.'s share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude